BioNxt Solutions Inc.
BNXT.CNCNQHealthcare● Active
$0.41
$-0.02(-3.57%)
Market Cap$52633395
P/E Ratio—
52W High$1.1
52W Low$0.34
BioNxt Solutions Inc. (BNXT.CN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BNXT.CN · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | 100.00% | 100.00% | 65.77% | 69.63% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.01B |
| Total Operating Expenses | $0.01B | $0.00B | $0.01B | $0.01B | $0.02B |
| Operating Income | ($0.01B) | ($0.00B) | ($0.01B) | ($0.01B) | ($0.02B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.02B) |
| Income Tax Expense | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) |
| Net Income | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.02B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.06 | $-0.05 | $-0.08 | $-0.15 | $-0.29 |
| Wtd Avg Shares | 0.12B | 0.11B | 0.10B | 0.08B | 0.07B |
| EBITDA | ($0.01B) | ($0.00B) | ($0.01B) | ($0.01B) | ($0.02B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · CAD · B
Explore more BioNxt Solutions Inc. data
About BioNxt Solutions Inc. (BNXT.CN) Income Statement
BioNxt Solutions Inc. (BNXT.CN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BNXT.CN reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.01B) — a net profit margin of —.
Frequently asked questions
BNXT.CN · 4 questionsBioNxt Solutions Inc. (BNXT.CN) reported revenue of $0.00B for 2025, down 100.0% year-over-year.
BNXT.CN revenueBNXT.CN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08